ELEDON PHARMACEUTICALS INC. - COMMON STOCK

Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

04 May 2023 15:05:03 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials

01 May 2023 06:00:00 By Nasdaq GlobeNewswire

Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology

31 Mar 2023 05:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Operating and Financial Results

30 Mar 2023 15:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023

23 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023

23 Mar 2023 07:00:02 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference

08 Feb 2023 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Provides Business and Pipeline Updates

09 Jan 2023 07:31:00 By Nasdaq GlobeNewswire

C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

21 Dec 2022 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results

14 Nov 2022 15:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

03 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS

24 Oct 2022 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in Two Upcoming Conferences

03 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference

22 Sep 2022 15:05:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy

06 Sep 2022 15:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29 Aug 2022 07:00:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results

11 Aug 2022 15:01:00 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

04 Aug 2022 15:05:03 By Nasdaq GlobeNewswire

Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation

18 Jul 2022 07:00:01 By Nasdaq GlobeNewswire

Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 Jun 2022 15:05:00 By Nasdaq GlobeNewswire